Therapeutic potential for P2Y2 receptor antagonism-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic potential for P2Y2 receptor antagonism

Published:2022-10-11 Issue: Volume: Page:
ISSN:1573-9538
Container-title:Purinergic Signalling
language:en
Short-container-title:Purinergic Signalling

Author:

Jasmer Kimberly J.^ORCID,Muñoz Forti Kevin^ORCID,Woods Lucas T.^ORCID,Cha Seunghee^ORCID,Weisman Gary A.^ORCID

Funder

National Institute of Dental and Craniofacial Research

Sjögren’s Syndrome Foundation

Wayne L. Ryan Foundation

Christopher S. Bond Life Sciences Center, University of Missouri

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Cellular and Molecular Neuroscience,Molecular Biology

Link

https://link.springer.com/content/pdf/10.1007/s11302-022-09900-3.pdf

Reference225 articles.

1. Di Virgilio F, Sarti AC, Falzoni S, De Marchi E, Adinolfi E (2018) Extracellular ATP and P2 purinergic signalling in the tumour microenvironment. Nat Rev Cancer 18(10):601–618

2. Zuccarini M, Giuliani P, Ronci M, Caciagli F, Caruso V, Ciccarelli R et al (2022) Purinergic signaling in oral tissues. Int J Mol Sci 23(14):7790

3. Woods LT, Forti KM, Shanbhag VC, Camden JM, Weisman GA (2021) P2Y receptors for extracellular nucleotides: contributions to cancer progression and therapeutic implications. Biochem Pharmacol 187:114406

4. Volonte C, D’Ambrosi N (2009) Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters. FEBS J 276(2):318–329

5. Murray JM, Bussiere DE (2009) Targeting the purinome. Methods Mol Biol 575:47–92

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the therapeutic capabilities of GPCR in the treatment of ischemic stroke: A translational literature;Medicine in Drug Discovery;2024-12

2. TICAGRELOR - MECHANISM OF ACTION AND ITS IMPACT ON DRUG EFFICACY;FARMACIA;2024

3. Comprehensive analysis of P2Y family genes expression, immune characteristics, and prognosis in pan-cancer;Translational Oncology;2023-11

4. The bumpy road of purinergic inhibitors to clinical application in immune-mediated diseases;Neural Regeneration Research;2023-10-02

5. ShlA toxin of Serratia induces P2Y2- and α5β1-dependent autophagy and bacterial clearance from host cells;Journal of Biological Chemistry;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3